Efficacy of sodium-glucose co-transporter-2 inhibitors in patients with heart failure-Reference-Cited by-同舟云学术

Efficacy of sodium-glucose co-transporter-2 inhibitors in patients with heart failure

Published:2021-02-17 Issue:1 Volume:26 Page:4235
ISSN:2618-7620
Container-title:Russian Journal of Cardiology
language:
Short-container-title:Russ J Cardiol

Author:

Kovalenko E. V.¹^ORCID,Lozhkina M. V.¹^ORCID,Arabidze G. G.¹^ORCID,Kryakushkin V. G.¹

Affiliation:

1. Moscow State University of Medicine and Dentistry

Publisher

Silicea - Poligraf, LLC

Subject

Cardiology and Cardiovascular Medicine

Reference34 articles.

1. Belenkov YuN, Mareev VYu, Ageev FT, et al. True prevalence of CHF in the European part of the Russian Federation (EPOCHA study, hospital stage). Journal of Heart Failure. 2011;12(2):63-8. (In Russ.)

2. Mareev VYu, Fomin IV, Ageev FT, et al. Clinical recommendations of OSSN-RKO-REPAIR. Heart failure: chronic (CHF) and acute decompensated (CHF). Diagnosis, prevention and treatment. Kardiologija. 2018;58(6S):8-158. (In Russ.) doi:10.18087/cardio.2475.

3. Mareev VYu, Belenkov YuN. Chronic heart failure and insulin-dependent diabetes mellitus random relationship or pattern. Therapeutic arkhive. 2003;75(10):1-10. (In Russ.)

4. American Diabetes Association. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes — 2020. Diabetes Care. 2020;43(Supplement 1):S98-S110. doi:10.2337/dc20-S009.

5. Packer M. SGLT2 inhibitors produce cardiorenal benefits by promoting adaptive cellular reprogramming to induce a state of fasting mimicry: a paradigm shift in understanding their mechanism of action. Diabetes Care. 2020;43(3):508-11. doi:10.2337/dci19-0074.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative efficacy of medication and cardiac resynchronization therapy in patients with heart failure with reduced ejection fraction;Russian Journal of Cardiology;2021-09-04